Please assess the completion status of the following clinical trial:

Trial Title: Long-term Study of DSP-5423P in Patients With Schizophrenia

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Patients who have schizophrenia diagnosed by DSM-5, diagnostic criteria~* Patients who are aged 18 years or older at informed consent~* Patient understands the objectives and procedures of the study and who provide written voluntarily consent to participate in the study, etc.~Exclusion Criteria:~* Patients who fall under a contraindication listed in the LONASEN® package insert~* Patients with Parkinson disease, etc.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- DSP-5423P (Type: EXPERIMENTAL): Percutaneous

Based on this trial design, predict the completion outcome and termination type (if applicable).